In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches

Abstract EN

Inosine 5′-monophosphate dehydrogenase (IMPDH) is one of the crucial enzymes in the de novo biosynthesis of guanosine nucleotides.

It has served as an attractive target in immunosuppressive, anticancer, antiviral, and antiparasitic therapeutic strategies.

In this study, pharmacophore mapping and molecular docking approaches were employed to discover novel Homo sapiens IMPDH (hIMPDH) inhibitors.

The Güner-Henry (GH) scoring method was used to evaluate the quality of generated pharmacophore hypotheses.

One of the generated pharmacophore hypotheses was found to possess a GH score of 0.67.

Ten potential compounds were selected from the ZINC database using a pharmacophore mapping approach and docked into the IMPDH active site.

We find two hits (i.e., ZINC02090792 and ZINC00048033) that match well the optimal pharmacophore features used in this investigation, and it is found that they form interactions with key residues of IMPDH.

We propose that these two hits are lead compounds for the development of novel hIMPDH inhibitors.